Proton Therapy for Partial Breast Irradiation: Rationale and Considerations

Area of Science:

• Oncology
• Radiation Oncology
• Medical Physics

Background:

• Personalized medicine advances offer new breast cancer treatment options.
• Partial Breast Irradiation (PBI) improves quality of life and shortens treatment duration.
• PBI reduces radiation exposure to non-target breast tissue, lowering toxicity.

Purpose of the Study:

• To review the rationale for using proton therapy in PBI for early-stage breast cancer.
• To present current evidence supporting proton therapy for PBI.
• To discuss practical implementation considerations for proton therapy in PBI.

Main Methods:

• Review of existing literature on proton therapy and PBI.
• Analysis of evidence regarding efficacy and toxicity.
• Discussion of technical and clinical implementation aspects.

Main Results:

• Proton therapy enhances PBI by further reducing radiation dose to normal tissues.
• This includes uninvolved breast tissue, heart, and lungs.
• Potential for improved outcomes and reduced side effects.

Conclusions:

• Proton therapy is a promising precision radiotherapy for PBI in select early-stage breast cancer patients.
• It builds upon PBI benefits by offering superior normal tissue sparing.
• Further evidence and practical considerations support its implementation.